2025, Volume 18, Issue 10, pp 976 – 978

Mixed-phenotype acute leukemia, not otherwise specified, rare types B/T leukemia: a case report in the Jordanian Royal Medical Services

Categories

Authors and Affiliations

* Corresponding author Mohammad Jasser Maaita, Princess Iman Center for Research and Laboratory Sciences, Jordanian Royal Medical Services, Amman, Jordan; E-mail: [email protected]

Abstract

Mixed phenotype acute leukemia (MPAL) represents approximately 3–5% of all acute leukemia cases and is defined by blast populations that co-express markers from more than one hematopoietic lineage. In most cases, blasts exhibit myeloid markers together with either B-cell or T-cell markers. The rarest subtype is mixed B/T acute leukemia. We report the case of a 7-year-old boy who presented with weakness and fatigue and was diagnosed with MPAL, not otherwise specified, B/T rare type, based on bone marrow examination and immunophenotyping. This case highlights the essential role of comprehensive immunophenotyping in establishing an accurate diagnosis of MPAL. Given the limited information in the literature, case series and prospective studies are needed for a better understanding and successful treatment.

Keywords

About this article

PMC ID: 
PubMed ID: 10.25122/jml-2025-0110
DOI: JMedLife-18-976

Article Publishing Date (print):
Available Online: 

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.

Categories